Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

SensCare

Financiado

AI-based wearable sensors for continuous monitoring of diabetes and cardiovascul...

AI-based wearable sensors for continuous monitoring of diabetes and cardiovascular diseases Cardiovascular diseases (CVDs) are the leading cause of death in Europe, with a total of 3.9 million deaths yearly, accounting for 45% of all deaths. Diabetes is another widely spread disease affecting 60 million people in the EU... ver más

31/03/2024

SENSAI TEKNOLOJI A...

75K€

Presupuesto del proyecto: 75K€

Líder del proyecto

SENSAI TEKNOLOJI ANONIM SIRKETI No se ha especificado una descripción o un objeto social para esta compañía.

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-03-31

HORIZON-EIE-2022-SCALEUP-02-02: Women TechEU ExpectedOutcome:Project results are expected to contribute to the following expected outcomes:

Innovación

Cerrada hace 2 años

0% 100% 100%

1 Participantes

SENSAI TEKNOLOJI ANONIM SIRK...

75.00K€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

PTQ-10-04051 PROTOTIPO PRENDA DE VESTIR CON SISTEMA INTEGRADO DE MONITORI... 53K€ Cerrado

2ND-CHANCE Implantable sensors and ultrasonic data link with triggered... 3M€ Cerrado

RTI2018-095324-B-I00 GESTION ADAPTATIVA Y PROACTIVA DE LA ENFERMEDAD CRONICA MEDI... 85K€ Cerrado

ARCHANGEL Advanced Remote Continuous patient Health mANaGemEnt SoLutio... 3M€ Cerrado

EUIN2013-51025 BIOSENSORES AUTONOMOS DESECHABLES PARA APLICACIONES BIOMEDIC... 18K€ Cerrado

PTQ-08-02-07428 SISTEMAS VESTIBLES DE MONITORIZACIÓN CONTINUA MULTIPARÁMETRO... 51K€ Cerrado

Duración del proyecto: 9 meses Fecha Inicio: 2023-06-07
Fecha Fin: 2024-03-31

Líder del proyecto

SENSAI TEKNOLOJI ANONIM SIRKETI No se ha especificado una descripción o un objeto social para esta compañía.

Presupuesto del proyecto 75K€

Descripción del proyecto Cardiovascular diseases (CVDs) are the leading cause of death in Europe, with a total of 3.9 million deaths yearly, accounting for 45% of all deaths. Diabetes is another widely spread disease affecting 60 million people in the EU (10% of the total population). Diabetes is the major cause of death in the age of 20-79. Also, Europe has the highest number of children with type-1 diabetes compared to other regions, with approximately 140,000 diagnosed children, and it has one of the highest prevalence rates of diabetes in children, with 21,600 new cases per year. Frequent glucose monitoring is critical for keeping blood glucose levels within a specific range to prevent potential cardiometabolic disease progression and pathophysiological changes. Current standard healthcare systems are passive and reactive, which deal with issues, incidents, and accidents after the opportunity to prevent damage to the patient has passed. With reactive healthcare, doctors provide treatment once patients contact them after developing noticeable symptoms. Actions are taken after things go wrong and sometimes after the opportunity to save the patient has passed. Besides, economically, reactive safety measures are costly in the long term. Moreover, this routine fails to prevent the onset of health conditions by prioritizing diagnostics and treatment. SensAI aims to tackle the limitations of centralized and reactive healthcare systems by taking a proactive approach using tailored, non-invasive, and personalized solutions (wearable monitoring devices) specifically developed for diabetes and CVDs without affecting peoples’ daily routines.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores